["Calcium gout" with nephrocalcinosis due to long-term dihydrotachysterine therapy].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D002118:Calcium / Q000097:blood; D004097:Dihydrotachysterol / Q000009:adverse effects* / Q000627:therapeutic use; D004492:Edetic Acid / Q000627:therapeutic use; D005260:Female; D006073:Gout / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy; D006225:Hand / Q000000981:diagnostic imaging; D006801:Humans; D008875:Middle Aged; D009397:Nephrocalcinosis / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy; D011859:Radiography; D011866:Radioisotope Renography; D012782:Shoulder / Q000000981:diagnostic imaging; D013746:Tetany / Q000188:drug therapy; D013997:Time Factors; D014805:Vitamin B 12 / Q000627:therapeutic use
D000324:Adrenocorticotropic Hormone; D004492:Edetic Acid; D014805:Vitamin B 12; D004097:Dihydrotachysterol; D002118:Calcium
"Kalkgicht" mit Nephrokalzinose, verursacht durch Langzeittherapie mit Dihydrotachysterin.